Pfeiffer Vacuum apprentices win award for virtual training film
Avoids translation misunderstandings as pumps firm expands into Asia
Alena Bölzer, Meike König, Oxana Pozdeev and Lisa Weichl won the ‘Unique products and services’ category for their virtual training films, which explain the steps involved in handling individual turbo pumps and other Pfeiffer Vacuum products. The films are practically speech-free so that any misunderstandings in language translation are avoided.
‘We are proud of our young employees,’ said Matthias Wierner, executive board member responsible for marketing, production and development at Pfeiffer Vacuum Technology. ‘They have not only had a great idea and implemented it well but have also presented their results professionally. Pfeiffer Vacuum will this year become even more international with a clear orientation towards Asia. We are very pleased that this situation is being addressed constructively and innovatively by all our staff.’
The company recently set up a subsidiary in São Paulo, Brazil and now has its own subsidiaries in Brazil, Russia, India and China.
Pfeiffer Vacuum reported unaudited sales of €220.5m in 2010, an increase of 21%.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
How CDMOs can set a new gold standard when it comes to going green
Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
Finance
Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
Finance
Newcells Biotech raises additional funding from investors
Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.